NASCSA BREAKING NEWS DEA Places Ezogabine in Schedule V The Drug Enforcement Administration (DEA) has issued a final rule to place Ezogabine into Schedule V of the Controlled Substance Act effective December 15, 2011. Ez

First Page		Document Content
Date: 2013-01-22 11:51:11 Office of National Drug Control Policy Pharmacology Carbamates Clinical pharmacology Drug Enforcement Administration Synthetic cannabis Controlled Substances Act Title 21 of the Code of Federal Regulations Gil Kerlikowske Drug policy of the United States Medicine Government		NASCSA BREAKING NEWS DEA Places Ezogabine in Schedule V The Drug Enforcement Administration (DEA) has issued a final rule to place Ezogabine into Schedule V of the Controlled Substance Act effective December 15, 2011. Ez Add to Reading List Source URL: www.nascsa.org Download Document from Source Website File Size: 79,56 KB Share Document on Facebook

	PDF Document DocID: 1xvUb - View Document
	PDF Document DocID: 1xc8R - View Document
	Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME DocID: 1vqsj - View Document
	Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia DocID: 1vlJU - View Document
	Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology DocID: 1vk1K - View Document